NOS2 and neoplasm: The pro-inflammatory phenotype (M1) serves as a key to tumor control by stimulating the immune system to produce high levels of pro-inflammatory cytokines: IL-1, IL-6, IL-12 [111], as well as by inducing T helper type 1 (Th1) and stimulating inducible nitric oxide synthase (iNOS) production [112].